NOS2 and glioblastoma: A total of 496 patients (with 362 gliomas including 176 glioblastomas and 134 meningiomas) were included in the study (see Section 2.3.5 and Section 2.4.8 “Brain Tumors” regardingNOS1 and NOS2).